Current pharmacogenetics in colorectal cancer--do they have an impact on our clinical treatment strategies?
Goekkurt
E
E
Department of Internal Medicine I, University Hospital Carl Gustav Carus, University Dresden, Germany.
Stoehlmacher
J
J
D000970:Antineoplastic Agents / Q000627:therapeutic use; D015415:Biomarkers; D015179:Colorectal Neoplasms / Q000188:drug therapy / Q000235:genetics*; D010597:Pharmacogenetics; D011110:Polymorphism, Genetic
D000970:Antineoplastic Agents; D015415:Biomarkers